These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 36624735)

  • 21. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary.
    Robinson LL; Sznajder NA; Riley SC; Anderson RA
    Mol Hum Reprod; 2001 Jul; 7(7):641-8. PubMed ID: 11420387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9.
    Coates-Park S; Lazaroff C; Gurung S; Rich J; Colladay A; O'Neill M; Butler GS; Overall CM; Stetler-Stevenson WG; Peeney D
    Matrix Biol; 2023 Nov; 123():59-70. PubMed ID: 37804930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
    Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
    Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
    Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression profiles in tracheal aspirates do not adequately reflect tracheal or lung tissue profiles in neonatal respiratory distress: observations from an animal model.
    Miller TL; Touch SM; Shaffer TH
    Pediatr Crit Care Med; 2006 Jan; 7(1):63-9. PubMed ID: 16395077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered matrix metalloproteinases and tissue inhibitors of metalloproteinases in embryos from diabetic rats during early organogenesis.
    Higa R; Kurtz M; Capobianco E; Martínez N; White V; Jawerbaum A
    Reprod Toxicol; 2011 Dec; 32(4):449-62. PubMed ID: 21963884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Continuing Saga of Tissue Inhibitor of Metalloproteinase 2: Emerging Roles in Tissue Homeostasis and Cancer Progression.
    Stetler-Stevenson WG
    Am J Pathol; 2023 Oct; 193(10):1336-1352. PubMed ID: 37572947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures.
    Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Samà D; Calatroni A
    Cell Biol Int; 2006 Jan; 30(1):21-30. PubMed ID: 16275145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual Timp deficiencies differentially impact pro-MMP-2 activation.
    English JL; Kassiri Z; Koskivirta I; Atkinson SJ; Di Grappa M; Soloway PD; Nagase H; Vuorio E; Murphy G; Khokha R
    J Biol Chem; 2006 Apr; 281(15):10337-46. PubMed ID: 16469749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
    Pohl M; Sakurai H; Bush KT; Nigam SK
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of extracellular matrix molecules, MMPs and TIMPs in alveolar bone, cementum and periodontal ligaments during rat tooth eruption.
    Maruya Y; Sasano Y; Takahashi I; Kagayama M; Mayanagi H
    J Electron Microsc (Tokyo); 2003; 52(6):593-604. PubMed ID: 14756248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressor of cytokine signaling 1-modulated metalloproteinases and tissue inhibitor of metalloproteinase in pulmonary fibrosis.
    Zhang Q; Guo Y; Dong R; Dai R; Zhou M
    Mol Med Rep; 2015 Sep; 12(3):3855-3861. PubMed ID: 25997387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
    Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
    Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.